株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

HIV・エイズ検査の世界市場

HIV/AIDS Testing

発行 Global Industry Analysts, Inc. 商品コード 138757
出版日 ページ情報 英文 306 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
HIV・エイズ検査の世界市場 HIV/AIDS Testing
出版日: 2015年10月01日 ページ情報: 英文 306 Pages
概要

当レポートでは、HIV・エイズ検査の世界市場に注目し、2014-2020年の期間を対象に量的規模および収益額の推移を製品セグメント (スクリーニング検査、確認検査、モニタリング検査) および地域 (米国、カナダ、日本、欧州、アジア太平洋地域、中南米、その他) の別に検証・予測するほか、過去7年にわたる市場経緯の分析や大小参入企業42社のプロファイルなど現在の競合環境についての調査情報をまとめています。

第1章 イントロダクション、調査方法、製品の定義

  • 調査の信頼性とレポートの限界
  • 免責事項
  • データの解釈とレポート作成レベル
    • 定量技法と分析法
  • 製品の定義と調査範囲
    • 定義

第2章 エグゼクティブサマリー

  • 産業概要
    • HIV・エイズ検査の世界市場 - 分析
    • 地域分析
    • セグメント分析
    • 競合
    • HIV・エイズ診断市場参入企業 - 製品マトリクス
    • FDA (米国食品医薬品局) /USAID (米国国際開発庁) 承認HIV簡易検査キット (2014年)
    • FDA承認HIV-1/2抗体およびHIV-1コンボアッセイ
  • 成長推進要因と市場動向
    • 簡易HIV検査 - 広大な成長性
    • 感染拡大を予防する簡易スクリーニング検査
    • 成長に貢献する新たなHIV試験
    • ウイルス量検査の動向
    • 勢力を増す在宅検査または自己検査
    • 自己検査:WHOの取り組み
    • 自己検査をめぐる課題
    • DNA-PCR (DNAポリメラーゼ連鎖反応)法
    • 開発段階にある商業HIVワクチン
    • 治験 (第二段階) 中のエイズワクチン一覧
    • 血液スクリーニング検査市場で力強い成長を見せる分子診断
    • HIV診断に寄与する救急治療室検査
    • HIV検査に弾みをつける市販検査キット
    • 機会指標
    • 引き続き需要に大きく貢献する中年顧客層
    • 今後の好況を示唆する女性ライダーの増加
  • HIV・エイズ統計値
    • エイズ - 世界的まん延
    • ファクトと数値
  • HIV・エイズ - この病気を理解する
    • 作用機序
    • 症状
    • 末期のエイズ
    • HIVの感染
    • 明るい側面
    • エイズ治療
    • 研究は続く
    • 艦船方法 - HIV治療の標的
  • HIV・エイズの診断
    • 検査 - エイズ予防および治療の基本
    • 血液加工
    • 最も早い感染発見時期
    • HIV検査の悩ましい問題点
    • HIV感染検査室診断の主な欠点
    • 簡易検査 - 開発途上国に適した方法
    • HIV検査
    • 厳格なルールに従っての検査
    • 診断試験
    • 分子診断および遺伝子検出製品
    • 技術検証
    • 規制
  • 製品認可および発売
  • 最新産業動向
  • 世界の主要参入企業
  • 世界市場見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • その他欧州諸国
  • アジア太平洋地域
  • 中南米
  • その他の地域

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-3401

This report analyzes the worldwide markets for HIV/AIDS Testing in Thousands (volume) and US$ Thousand (value) by the following Product Segments: HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 42 companies including many key and niche players such as -

Abbott Laboratories, Inc.
Adaltis S.r.l.
Alere
Beckman Coulter, Inc.
bioMerieux SA

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Definitions
      • HIV/AIDS Screening Tests
      • HIV/AIDS Confirmatory Tests
      • HIV/AIDS Monitoring Tests

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • Worldwide HIV/AIDS Testing Market - An Analysis
  • Regional Analysis
  • Segment Analysis
    • HIV/AIDS Screening Tests
    • HIV/AIDS Confirmatory Tests
    • HIV/AIDS Monitoring Market
  • Competition
  • HIV/AIDS Diagnostics Market Participants - Product Matrix
  • FDA/USAID Approved HIV Rapid Test Kits (2014)
  • FDA-Approved Anti-HIV-1/2 and HIV-1 Antigen Combo Assays

2. GROWTH DRIVERS AND MARKET TRENDS

  • Rapid HIV Tests - Vast Growth Potential
  • Rapid Screening Tests Prevent Epidemic Spread
  • New HIV Assays to Fuel Growth
  • Trends in Viral Load Testing
    • Table 1: Viral Load Volumes by Region: Percentage Share of Viral Load Test Volumes for South Africa, Sub-Saharan Africa, and Rest of World (2015, 2017E, & 2019E) (includes corresponding Graph/Chart)
    • Table 2: Viral Load Testing Potential by Setting: Percentage Share of Viral Load Test Volumes for District Hospitals, Large Urban Clinics, and Small Rural Clinics (2015, 2018E, & 2020E) (includes corresponding Graph/Chart)
  • Home Testing or Self-Testing to Gain Strength
  • Self Testing: WHO Initiatives
  • Challenges Involved in Self-Testing
  • DNA-PCR: Preferred Technique for Early Infant Diagnosis (EID)
  • Commercial HIV Vaccines in the Pipeline
  • List of Clinical Trial (Phase II) AIDS Vaccines - 2015
  • Molecular Diagnostics Register Strong Growth in Blood Screening Markets
  • Emergency Room Testing to Help HIV Diagnosis
  • OTC Tests Provide Momentum to HIV Testing

3. HIV/AIDS STATISTICS

  • AIDS: A Global Epidemic
  • Facts & Figures
    • Table 3: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart)
    • Table 4: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart)
    • Table 5: Worldwide AIDS related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart)
    • Table 6: HIV Prevalence (%) in Adults (15-49 years) by Year: Prevalence Percentage in Adults in 1990, 2000, 2008 & 2014 (includes corresponding Graph/Chart)
    • Table 7: HIV Testing Service Penetration, by Region (2010-2014): Percentage Share of Adults who received HIV Testing Services in Various Global Regions (includes corresponding Graph/Chart)
    • Table 8: HIV Testing Services Availed, by Gender (2014): Percentage Breakdown of Women and Men in all WHO Regions (includes corresponding Graph/Chart)
    • Table 9: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart)
    • Table 10: International & Domestic Spending on ART in Low/Middle-Income Countries, by Region (2013): Expenditure in Millions up to 2013 (includes corresponding Graph/Chart)
    • Table 11: No. of People on Antiviral therapy in Low/Middle-Income Countries, by Region: Numbers in 2012, 2013 & 2014 (includes corresponding Graph/Chart)
    • Anti-AIDS Therapeutics: A Blessing in Disguise in Developed Countries
  • 4. HIV/AIDS: UNDERSTANDING THE DISEASE
  • Mechanism of Action
  • Symptoms
  • Full-Blown AIDS
  • Transmission of HIV
  • On the Brighter Side
  • HIV Therapy
  • The Search Continues
  • Infection Process - Targets for HIV Therapy
  • 5. DIAGNOSIS OF HIV/AIDS
  • Testing: The Basis for AIDS Prevention and Treatment
  • Blood Processing
  • The Earliest Time to Detect Infection
  • Problems Plaguing HIV Testing
  • Major Drawbacks of Laboratory Diagnosis of HIV Infections
  • Rapid Tests - SuiTable for Developing Countries
  • HIV Tests
  • Testing Subject to Strict Rules
  • Diagnostic Tests
    • I. Antibody Tests
      • A. HIV-1 Screening Tests
      • Test Methodology
      • a. Enzyme-linked Immunosorbent Assays/ Enzyme Immunoassays (ELISA/EIA)
      • b. Home Access HIV-1 test system/Dried Blood Spot
      • c. Rapid Tests
      • B. HIV-1 Antibody Confirmatory Tests
      • a. The Western Blot Test
      • Commonly Used in Developed Countries
      • Interpretation of Results
      • Modified Western Blots
      • b. Indirect Immunofluorescent Antibody Assay (IFA)
      • c. Line Immunoassay
      • d. Radioimmunoprecipitation Assay (RIPA)
      • C. HIV-2 Diagnostic Tests and HIV Group "O
      • Testing Protocols
      • Types of Antibody Tests Based on Sample
      • i. Traditional Blood Antibody Tests
      • ii. Dried Blood Spot (DBS) Sampling Technique
      • iii. Other Alternatives in Samples
      • Oral Testing for HIV
      • Urine Tests
    • II. Viral Identification Assays
      • A. p24 Antigen Test
      • B. Qualitative PCR Tests
      • PCR: The Process
      • C. Viral Culture
    • III. Monitoring Tests
      • A. Lymphocyte Analysis
      • CD4 Cell Counts
      • B. Viral Load Tests
      • Indicator of Successful Therapy
      • Levels of CD4 and Viral Load in AIDS
    • Molecular Diagnostics and Gene Detection Products
      • DNA Probe-Based Products
      • Direct Assays
      • Amplification
      • Amplification Methodologies
      • DNA Chips
      • Growth of DNA Chips Influenced by HIV Research
    • Technology Review
      • Home HIV Tests: Unfolding a New Era of Testing
      • PCR: A Promising Development in HIV/AIDS Monitoring Market
      • DNA Probes are Highly Specific and Sensitive
      • OCA-particles Based Detection System-Offers Increased Accuracy
      • Drawbacks of Blood-Based Tests
    • Regulations
      • Regulatory Overview
      • UN's Testing Policies in Peacekeeping Force
      • Anonymous versus Confidential Diagnostic Testing for HIV infection in US
      • Regulatory Approval for Rapid HIV Test Kits in US
      • HIV Testing - Mandatory in US Blood Banks

6. PRODUCT APPROVALS & LAUNCHES

  • BioPlex(r) 2200 HIV Ag-Ab Assay Receives FDA Pre-market Approval
  • Beckman Coulter Obtains CE Marking for DxN VERIS HIV-1 Assay
  • Chembio Receives CE Mark Approval for its DPP(r) HIV 1/2 Assay
  • BioSure UK Launches HIV Home Testing Kit
  • USFDA Approves cobas(r) TaqScreen MPX Test by Roche Diagnostics
  • Xpert(r) HIV-1 Viral Load Test Acquires CE-IVD Status
  • Hologic Announces CE Mark Certification for its Aptima HIV-1 Quant Dx Assay
  • Bio-Rad's Geenius(tm) HIV 1/2 Supplemental Assay Receives USFDA Pre-market Approval
  • LabCorp Launches HIV GenoSure ArchiveSM Test to Optimize Drug Regimens
  • DiaSorin Launches Liaison XL Murex HIV Ab/Ag High Throughput Test
  • Bio-Rad Launches BioPlex 2200 HIV Ag-Ab Kit for Ex-US Markets
  • MedMira Receives Approval to Market Enhanced Version of Reveal HIV Test in Europe
  • Roche Receives CE Certification to Launch Dual target COBAS Test
  • Theradig and CNRS to Develop Theranostics HIV/AIDS Tests
  • LabCorp Introduces HIV Ag/Ab Combination Assay and Screening Algorithm
  • Alere Launches Rapid POC Determine HIV 1/2 Ag/Ag Combo Test

7. RECENT INDUSTRY ACTIVITY

  • DiaSorin and Beckman Coulter Sign Distribution Partnership Agreement
  • Global Initiative Lowers Price of Infant Early HIV Diagnostic Technologies
  • USAID Project to Deliver HIV Testing Services in Africa
  • Roche to Provide HIV-1 Viral Load and Early Infant Diagnostic Technologies for Global Fund
  • Bio-Rad and Beckman Coulter Extend Distribution Agreement
  • Case Western Reserve University Hospital Signs Agreement with Advanced Biological Laboratories
  • UNAIDS Collaborates with Global Partners to Launch Diagnostics Access Initiative
  • Zyomyx Acquires $7.5 M from WHO to Market MyT4 CD4 Test in Developing World
  • Daktari Diagnostics Seeks Funding for HIV Test Manufacturing Capacity
  • Gilead Sciences and Good Samaritan Foundation Enter Into Partnership to Provide HIV Testing in Africa
  • Chembio Signs Technology License, Distribution & Manufacturing Agreements with RVR Diagnostics SDN BHD
  • Mylan Signs Exclusive Distribution Agreement with Zyomyx for POC CD4 Test
  • Calypte Biomedical and Maxim Sign Joint Distribution Agreement for HIV Tests

8. FOCUS ON SELECT GLOBAL PLAYERS

  • Abbott Laboratories, Inc. (US)
  • Abbott Molecular, Inc. (US)
  • Adaltis S.r.l. (Italy)
  • Alere (US)
  • Beckman Coulter, Inc. (US)
  • bioMerieux SA (France)
  • Bio-Rad Laboratories, Inc. (US)
  • Calypte Biomedical Corporation (US)
  • Chembio Diagnostic Systems, Inc. (US)
  • Hologic, Inc. (US)
  • Fujirebio Europe N.V. (Belgium)
  • MedMira Inc. (Canada)
  • OraSure Technologies, Inc. (US)
  • Ortho-Clinical Diagnostics, Inc. (US)
  • Quest Diagnostics, Inc. (US)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare Diagnostics, Inc. (US)
  • Trinity Biotech Plc. (Ireland)

9. GLOBAL MARKET PERSPECTIVE

  • Unit Analytics
    • Table 12: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 14: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 15: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 16: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 17: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 18: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 19: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 20: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • Dollar Analytics
    • Table 21: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 22: World Historic Review for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 23: World 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
  • HIV/AIDS Testing by Test Type
    • Table 24: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 25: World Historic Review for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 26: World 14-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 27: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 28: World Historic Review for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 29: World 14-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 30: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 31: World Historic Review for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 32: World 14-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Outlook
    • Government Mandates and Reimbursement Policies Aid Market Growth
      • List of Key Milestones in HIV Testing & Reimbursement
    • HIV Tests Available in the US Market
      • Anti-HIV-2 Assay (to detect antibodies to Human Immunodeficiency Virus type 2)
      • Anti-HIV-1/2 Assays (to detect antibodies to Human Immunodeficiency Virus types 1 and 2)
      • FDA Approved HIV/AIDS Tests in the US Market: 2015
    • Competitive Structure
    • Table 33: The US HIV POCT Market by Player (2014): Percentage Share of Sales for Chembio, OraSure Blood Tests, Orasure Saliva Tests, and Trinity (includes corresponding Graph/Chart)
    • Rapid HIV Tests Gain Popularity
      • FDA/USAID Approved HIV Rapid Test Kits (2014)
    • Home HIV Tests Abate Privacy Concerns
    • NAT Tests Score High in Blood Banks
    • Major End-Users of HIV/AIDS Tests
    • HIV Testing Made Mandatory in Blood Banks
    • HIV/AIDS Statistics
    • Table 34: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart)
    • Table 35: AIDS Diagnoses in the US by Ethnic Group (Through 2013): Percentage Share of AIDS Diagnosis for Blacks, Asians, Hispanics, Native Hawaiian, Native/American Indians, Whites, and Multiple Races (includes corresponding Graph/Chart)
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Unit Analytics
    • Table 36: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 37: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 38: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 39: The US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 40: The US Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 41: The US 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Outlook
    • HIV Statistics
    • Table 42: Age Group Distribution of Reported HIV cases in Canada by Gender: 1985-2013 (includes corresponding Graph/Chart)
    • Table 43: No. of Reported HIV Cases: 2005-2013 (includes corresponding Graph/Chart)
    • Table 44: HIV Cases Reported in Canada by Ethnicity and Mode of Exposure (1998-2013): % Breakdown of Reported HIV cases Among different Ethnic Groups for Men who have sex with Men (MSM), Injection Drug Users (IDU), MSM/IDU, Heterosexuals, and Others (includes corresponding Graph/Chart)
    • Table 45: HIV Diagnosis Rate in Canada by Province: 2013 (includes corresponding raph/Chart)
    • Medmira Inc. - A Key Player
  • B. Market Analytics
    • Unit Analytics
    • Table 46: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 47: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 48: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 49: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 50: Canadian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 51: Canadian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Table 52: HIV Occurrence in Japan by Mode of Transmission (2014): Percentage Share of HIV Transmission by Homosexual Contact, Heterosexual contact, Congenital Transmission, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart)
    • Table 53: AIDS Occurrence in Japan by Mode of Transmission (2014): Percentage Share of AIDS Transmission by Homosexual Contact, Heterosexual contact, Intravenous Drug use, Unknown Causes, and Others (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Unit Analytics
    • Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 55: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 56: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 57: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 58: Japanese Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 59: Japanese 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Outlook
    • Regional Analysis
    • Segment Analysis
    • Aids/Hiv Stats - A Review
      • Western Europe
    • Table 60: HIV/AIDS Prevalence in Western Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
      • Central Europe
    • Table 61: HIV/AIDS Prevalence in Central Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
      • Eastern Europe
    • Table 62: HIV/AIDS Prevalence in Eastern Europe: Facts and Figures by Country (2011) (includes corresponding Graph/Chart)
    • Regulations
      • Antenatal HIV Testing in Europe
  • B. Market Analytics
    • Unit Analytics
    • Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 64: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 65: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 67: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 68: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 70: European Historic Review for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 71: European 14-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Table 72: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 73: European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 74: European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Pharmacies Start OTC Sales of HIV Home Testing Kits
    • Product Launch
    • BioMerieux SA - A Key Player
  • B. Market Analytics
    • Unit Analytics
    • Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 76: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 77: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 78: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 79: French Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 80: French 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4b. GERMANY

  • Market Analysis
    • Unit Analytics
    • Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 82: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 83: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 84: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 85: German Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 86: German 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4c. ITALY

  • A. Market Analysis
    • Outlook
    • Table 87: HIV/AIDS Prevalence Rates by Age Group in Italy: End of 2011 (includes corresponding Graph/Chart)
    • Product Launch
    • Key Player - Adaltis S.R.L.
  • B. Market Analytics
    • Unit Analytics
    • Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 89: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 90: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 91: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 92: Italian Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 93: Italian 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Outlook
    • HIV and AIDS Statistics
    • Table 94: HIV Prevalence in the UK by Mode of Transmission (2013): Number of HIV Infections Estimated in MSM, People who Inject Drugs, and Heterosexuals (includes corresponding Graph/Chart)
    • Table 95: HIV Prevalence in the UK in Heterosexuals (2013): Number of HIV Infections Estimated in Heterosexual Men and Women of African Ethnicity and Non-African Ethnicity (includes corresponding Graph/Chart)
    • Table 96: New cases of HIV Diagnoses among Heterosexuals by Age Group (2013): Number of New HIV Infections in Heterosexuals of 15-24, 25-39, 40-49, & 50+ Age Groups (includes corresponding Graph/Chart)
    • Product Launch
  • B. Market Analytics
    • Unit Analytics
    • Table 97: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 98: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 99: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 100: The UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 101: The UK Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 102: The UK 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Unit Analytics
    • Table 103: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 104: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 105: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 106: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 107: Spanish Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 108: Spanish 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

4f. REST OF EUROPE

  • A. Market Analysis
    • Outlook
    • Ukraine
    • Austria
    • Other European Countries
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Unit Analytics
    • Table 109: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 110: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 111: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 112: Rest of European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 113: Rest of European Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 114: Rest of European 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Outlook
    • The Next Epicenter for the AIDS Epidemic
    • Table 115: AIDS/HIV Stats in Asia (2014)
    • Review of Select Asian Countries
      • Australia
    • Table 116: Number of HIV and AIDS Cases in Australia: 2005 to 2011 (includes corresponding Graph/Chart)
    • Table 117: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2011 (includes corresponding Graph/Chart)
      • China
      • AIDS/HIV - A Review
      • Efforts to Combat HIV/AIDS
      • India - HIV Concentrated in South and Northeast
    • Table 118: Estimated Living Population in India with HIV/AIDS Infection (2009)
    • Table 119: Prevalence of TB in HIV Patients In India (2010-2013): Total No. of People Attending HIV testing centres, Diagnosed TB cases, and the percentage of HIV-Positive TB patients started on ART (includes corresponding Graph/Chart)
      • Thailand
      • HIV Cases on Decline
    • Table 120: Number of Live Persons Infection with HIV in Thailand, by Category (2011-End): Percentage breakdown of Adult Men & Women, and Children with HIV Infection (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Unit Analytics
    • Table 121: Asia-Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 122: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 123: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 124: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 125: Asia-Pacific Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 126: Asia Pacific 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • A. Market Analysis
    • Outlook
    • HIV Epidemic in Latin America
    • Table 127: People Living with HIV Infection in Latin America by Country: 2011 (includes corresponding Graph/Chart)
    • Trends and Transmission Modes
    • Trends in Antiretroviral Treatment
  • B. Market Analytics
    • Unit Analytics
    • Table 128: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 129: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 130: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 131: Latin American Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 132: Latin American Historic Review for HIV/AIDS Testing by Test Type - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 133: Latin American 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Outlook
    • Africa: Epicenter of the HIV Epidemic
    • Table 134: HIV/AIDS Cases in Africa as of 2011-End: Breakdown by Top 20 Countries (includes corresponding Graph/Chart)
    • Table 135: Adults & Children Deaths Due to AIDS in Africa (2011): Breakdown by Top 10 Countries (includes corresponding Graph/Chart)
    • Sub-Saharan Africa
    • Table 136: AIDS/HIV Stats in Sub-Saharan Africa (2011)
    • Southern Africa
    • East, West and Central Africa
    • South Africa - The HIV/AIDS Hub
    • Uganda - A Review
    • Caribbean Nations
    • Table 137: AIDS/HIV Stats in the Caribbean Nations (2011)
    • Table 138: HIV/AIDS Prevalence in Caribbean Nations: 2014 (includes corresponding Graph/Chart)
    • Strategic Corporate Developments
  • B. Market Analytics
    • Unit Analytics
    • Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 140: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in Thousand Units for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 141: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)
    • Dollar Analytics
    • Table 142: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
    • Table 143: Rest of World Historic Review for HIV/AIDS Testing by Test Type - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
    • Table 144: Rest of World 14-Year Perspective for HIV/AIDS Testing by Test Type - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2007, 2015 & 2020 (includes corresponding Graph/Chart)

COMPETITIVE LANDSCAPE

Back to Top